I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 21 studies | 26% ± 7% | |
| microglial cell | 10 studies | 30% ± 11% | |
| non-classical monocyte | 9 studies | 25% ± 10% | |
| oligodendrocyte precursor cell | 8 studies | 31% ± 15% | |
| endothelial cell | 7 studies | 29% ± 10% | |
| natural killer cell | 7 studies | 17% ± 1% | |
| monocyte | 7 studies | 24% ± 6% | |
| GABAergic neuron | 7 studies | 36% ± 20% | |
| astrocyte | 7 studies | 32% ± 12% | |
| interneuron | 6 studies | 37% ± 22% | |
| epithelial cell | 6 studies | 34% ± 11% | |
| retinal rod cell | 6 studies | 28% ± 8% | |
| classical monocyte | 5 studies | 26% ± 9% | |
| glutamatergic neuron | 5 studies | 47% ± 21% | |
| myeloid cell | 5 studies | 31% ± 9% | |
| retinal cone cell | 5 studies | 26% ± 6% | |
| dendritic cell | 5 studies | 27% ± 13% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 19% ± 2% | |
| neuron | 4 studies | 27% ± 7% | |
| B cell | 4 studies | 22% ± 6% | |
| CD8-positive, alpha-beta T cell | 4 studies | 17% ± 2% | |
| oligodendrocyte | 4 studies | 26% ± 7% | |
| plasmacytoid dendritic cell | 4 studies | 21% ± 5% | |
| CD4-positive, alpha-beta T cell | 3 studies | 19% ± 1% | |
| conventional dendritic cell | 3 studies | 34% ± 15% | |
| hematopoietic precursor cell | 3 studies | 21% ± 5% | |
| mast cell | 3 studies | 23% ± 9% | |
| lymphocyte | 3 studies | 17% ± 1% | |
| transit amplifying cell | 3 studies | 24% ± 7% |
